Understanding Chiral Technologies; Costs, Sales and Market Overview

PRLog (Press Release) - Mar 24, 2009 -
Phoenix, AZ – “Understanding Chiral Technologies,” a report published by Pharma-Reports.com analyzes the technology involved in the chiral processes, cost of the technology, worldwide sales, the different chiral models, major players in the industry, and the basics of the chiral industry. Market overview and market statistics are also included in this report.

Some of the fastest growing new drugs today are chiral molecules - those whichthat can exist as two mirror-image isomers. Approximately 80% of all products currently in development for the pharmaceutical industry are based on chiral building blocks, according to Karlheinz Drauz, vice president for technology and R&D management in the fine chemicals business unit of Degussa AG in Hanau-Wolfgang, Germany.

Global revenues from chiral technology soared from $6.63 billion in 2000 to $16.03 billion in 2007, growing at a compound annual rate of 13.4% during that period.

Other Topics covered in this report include: Worldwide Sales and Market Presence of Single Isomer Drugs; Bringing the Molecule to a Commercial Scale; Role of the Pharmaceutical Industry in Promoting Chiral Technologies; and End-Users of Chiral Technologies, including: (i)   Agrochemicals; (ii)   Pharmaceuticals; and   (iii)  Flavors, Fragrances, and Other Industries.       .

About the Publisher: "Understanding Chiral Technologies" is published by Pharma-Reports (www.Pharma-Reports.com), a pharmaceutical and biotechnology industry think tank and leading source for pharmaceutical and biotechnology industry information and research products.  

View details of this report at http://www.pharma-reports.com/shop/item.asp?itemid=319&af...

Photo:
http://www.prlog.org/10193986/1